Correlation Between Monte Rosa and ATyr Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and ATyr Pharma, you can compare the effects of market volatilities on Monte Rosa and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and ATyr Pharma.

Diversification Opportunities for Monte Rosa and ATyr Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Monte and ATyr is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Monte Rosa i.e., Monte Rosa and ATyr Pharma go up and down completely randomly.

Pair Corralation between Monte Rosa and ATyr Pharma

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 1.16 times more return on investment than ATyr Pharma. However, Monte Rosa is 1.16 times more volatile than ATyr Pharma. It trades about 0.03 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.03 per unit of risk. If you would invest  902.00  in Monte Rosa Therapeutics on August 28, 2024 and sell it today you would lose (56.00) from holding Monte Rosa Therapeutics or give up 6.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy76.57%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  ATyr Pharma

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.
ATyr Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Monte Rosa and ATyr Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and ATyr Pharma

The main advantage of trading using opposite Monte Rosa and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.
The idea behind Monte Rosa Therapeutics and ATyr Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamental Analysis
View fundamental data based on most recent published financial statements
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings